HealthCor Catalio Acquisition Corp. (NASDAQ:HCAQ) announced in an 8-K filing that its shareholders approved its combination with medical technology firms Hyperfine and Liminal Sciences, albeit with high redemptions, at a special meeting yesterday.
A total of 17,142,244 shares were redeemed in connection with the vote, removing about $171.4 million from its estimated trust of $207 million heading into the vote. This should not pose any risk to the transaction’s close, however, as the parties agreed to a $125 million minimum cash condition, which was fully met by the deal’s $126.1 million PIPE, regardless of redemptions.
The deal is expected to close later today and the combined entity is expected to begin trading on the Nasdaq on December 23 under the symbol “HYPR”.
The parties initially announced the $580 million combination on July 8. Hyperfine created the first FDA approved portable MR Imaging System which allows the technology to be accessible at anytime, anywhere, and to any patient. Liminal Sciences is building a device to non-invasively measure key vital signs in the brain to enable unprecedented access to dramatically improve patient outcomes.
All measures on HealthCor’s ballot passed by wide margins but about 23% shares dissented against a number of charter proposals. For full vote tallies, click here.
ADVISORS
- J.P. Morgan is acting as exclusive financial advisor to Hyperfine and Liminal.
- Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. is serving as legal advisor to Hyperfine and Liminal.
- Jefferies LLC acted as financial advisor to HealthCor Catalio Acquisition Corp.
- Jefferies LLC and Evercore Group L.L.C. acted as capital markets advisors and co-lead placement agents to HealthCor Catalio Acquisition Corp. in connection with the private placement.
- Wells Fargo Securities also acted as capital markets advisor and placement agent to HealthCor Catalio Acquisition Corp. in connection with the private placement.
- Kirkland & Ellis LLP and Paul Hastings LLP are serving as legal advisors to HealthCor Catalio Acquisition Corp. and the private placement agents.
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...
At the SPAC of Dawn Futures sit slightly red as investors return from holidays of barbecues and fireworks to renewed concerns about where US President Donald Trump’s tariff policy might hamper trade. The latest shift produced a further one-month delay in most of the tariffs Trump has threatened to impose as his administration continues to...
Terms Tracker for the Week Ending July 3, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re heading into the July 4th holiday, so we’ll keep this week’s column short and to the point. But before you head to the beach,...
Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...